Abstract:OBJECTIVE To explore the clinical characteristics of the co-morbidity of vasovagal syncope (VVS) and postural tachycardia syndrome (POTS) with allergic diseases in children. METHODS A re-trospective analysis was launched to summarize the clinical data of children with VVS and POTS. They were divided into allergic group and non-allergic group according to the history of allergic diseases. The participants' clinical characteristics were compared between allergic group and non-allergic group using independent sample t test or rank sum test; composition comparisons were completed by Chi-square test. Bi-variate correlation analysis was used to explore the association between eosinophil percentage/count and symptom scores/frequency of syncope episodes. A P value <0.05 was defined as statistically significant. RESULTS Sixty-seven children complaining of orthostatic intolerance (43 patients diagnosed as VVS and 24 cases diagnosed as POTS) were enrolled. Totally 21 cases (31%) had allergic diseases, including allergic rhinitis, atopic eczema, asthma, as well as food allergy. And allergic rhinitis is the most common co-morbidity. There were no significant differences between the two groups in age, gender ratio, height, body weight and basement blood pressure. Compared with the non-allergic group, the allergic group showed later onset age (year) (11±2 vs. 9±3, P<0.05) of orthostatic intolerance and shorter course of the diseases (month) [8.0 (0.1, 0.1) vs. 24.0 (0.1, 144.0), P<0.05]. The frequency of syncope episodes in the allergic group among VVS children (times per month) [2.50 (0.08, 30.00) vs. 0.25 (0.03, 5.00), P<0.05] was much higher than that in the non-allergic group. Additionally, the eosinophil percentage (%) [3.50 (0.70, 0.59) vs. 1.65 (0.30, 6.20), P<0.001] and eosinophil count (×109) [0.18 (0.05, 0.71) vs. 0.10 (0.02, 0.38), P<0.001] were increased in the allergic group. However, there were no remarkable differences in the results of head-up tilt test in children with VVS or in the maximum change of heart rate during standing test in children with POTS were involved. CONCLUSION Allergic diseases are common co-morbidities in children with both VVS and POTS. Allergic rhinitis is the most common co-morbidity. Children with co-morbidity of VVS/POTS and allergic diseases had a later onset of symptoms of orthostatic intolerance, and were more likely to be hospitalized for intensive attacks of symptoms during a short period when compared with those without allergic diseases. Children diagnosed as VVS combined with allergic diseases had more frequent episodes of syncope.

Impact of Comorbidities on the Prognosis of Pediatric Vasovagal Syncope

Research progress on the predictive value of electrocardiographic indicators in the diagnosis and prognosis of children with vasovagal syncope

Comorbidity of Neurally Mediated Syncope and Allergic Disease in Children.

Relationship between hemodynamic type and syncopal symptoms in pediatric vasovagal syncope

Analysis of the factors related to recurrent vasovagal syncope in children

Research progress of mechanisms for vasovagal syncope in children

Selective Anatomical Catheter Ablation of Left Atrial Ganglionated Plexus for Vasovagal Syncope: Left Superior and Right Anterior Ganglionated Plexus Ablation

Development of prognostic nomogram model to predict syncope recurrence in children with vasovagal syncope

[Co-Morbidity of Vasovagal Syncope and Postural Tachycardia Syndrome with Allergic Diseases in Children].

Factors affecting the syncopal episodes in pediatric vasovagal syncope

Advances in the role of vascular endothelial system in the pathogenesis of vasovagal syncope in children

Predictor of Syncopal Recurrence in Children With Vasovagal Syncope Treated With Metoprolol

[Diagnosis and Treatment of Malignant Vasovagal Syncope in Children].

[Relationship Between Blood Routine Test Parameters and Syncopal Recurrence of Vasovagal Syncope in Children].

Development of a nomogram model to predict malignant vasovagal syncope in Chinese children

Follow-up study of the efficacy of different therapies on vasovagal syncope in children with different hemodynamic patterns

Risk Factors and Prognostic Follow-Up of Vasovagal Syncope Children With Seizure-Like Activities During Head-Up Tilt Test Induced-Syncope

Plasma Neuropeptide Y Levels in Vasovagal Syncope in Children

Spectrum of underlying diseases in syncope and treatment of neurally-mediated syncope in children and adolescents over the past 30 years: A single center study

Alteration of Gene Expression Profiling Including GPR174 and GNG2 is Associated with Vasovagal Syncope

Cost-effectiveness of Diagnostic Approaches to Vasovagal Syncope.